Pfizer Center for Therapeutic Innovation
Pfizer Center for Therapeutic Innovation
Pfizer Center for Therapeutic Innovation
Pfizer Center for Therapeutic Innovation
Pfizer Center for Therapeutic Innovation
Pfizer Center for Therapeutic Innovation
Pfizer Center for Therapeutic Innovation

Pfizer

Center for Therapeutic Innovation, Boston, MA

Pfizer has located its corporate headquarters for the Center for Therapeutic Innovation group in the Center for Life Science | Boston (CLSB) building on the top floor, in the heart of the Longwood Medical Area. The strategic decision to develop three Centers for Therapeutic Innovation (CTI), in Boston, New York and San Francisco, is part of a global initiative to foster new collaborations with the city’s major medical centers and institutions (Beth Israel Deaconess Medical Center, Boston University Medical Center, Children’s Hospital Boston, Harvard Medical School, Partners HealthCare, Tufts Medical Center and the University of Massachusetts Medical School) with the goal of accelerating research and drug development. Comprised of open, flexible space, labs are easily reconfigured to accommodate the movement of cutting-edge equipment, evolving technology and a frequently shifting research focus.

Key Features

  • Modular, open-plan office areas maximize the deep penetration of natural light and offer striking views of Boston.
  • Small, glass enclosed 'touch-down' rooms and 'markerboard' paint in corridors are provided along major circulation paths to encourage impromptu meetings and collaboration. Perforated metal accents and strong linear forms reinforce a modern culture and create way finding cues upon arrival.
  • Full height glass doors and an electric glazed operable garage door separate the main conference center from the lobby. These features, combined with a tackable room divider partition, allow for flexible configurations within the space. Such flexibility was considered a key element in relating the function of the limited space to the brand identity of the CTI group.